BioCryst Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 15, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	26,832	32,457	20,740	41,746	51,090	26,175
Market Cap Growth	-16.14%	56.49%	-50.32%	-18.29%	95.19%	161.10%
Enterprise Value	34,913	43,128	28,311	47,499	53,366	24,930
Last Close Price	118.00	155.00	113.92	215.00	255.00	148.00
PS Ratio	2.44	3.46	3.70	7.90	15.86	73.85
PB Ratio	-3.77	-3.27	-2.69	-7.26	-23.29	-68.29
EV/Sales Ratio	3.39	4.59	5.05	8.99	16.56	70.34
EV/EBITDA Ratio	24.60	1194.32	-	-	-	-
Debt / Equity Ratio	-1.76	-1.77	-1.86	-2.52	-5.54	-14.51
Debt / EBITDA Ratio	8.27	208.58	-	-	-	-
Asset Turnover	1.28	0.90	0.62	0.48	0.34	0.07
Inventory Turnover	29.60	10.11	7.71	12.00	18.93	-
Quick Ratio	1.60	2.49	2.97	4.50	5.18	2.93
Current Ratio	1.87	2.63	3.31	4.89	5.46	3.07
Return on Equity (ROE)	-	-	-	-	-	-1925.37%
Return on Assets (ROA)	10.31%	-0.16%	-11.57%	-16.30%	-24.07%	-41.60%
Return on Capital Employed (ROCE)	30.20%	-0.40%	-26.90%	-33.40%	-36.70%	-74.10%
Earnings Yield	-0.60%	-5.71%	-18.47%	-11.55%	-7.39%	-13.90%
FCF Yield	3.27%	-3.41%	-7.93%	-7.63%	-5.80%	-10.31%
Buyback Yield / Dilution	-1.84%	-7.54%	-3.38%	-3.79%	-7.08%	-44.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.